ENDOCYTE INC Insider Trading for February 2014
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ENDOCYTE INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ENDOCYTE INC for February 2014.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 18 2014 | ECYT | ENDOCYTE INC | Low Philip S | Chief Science Offic ... | Sell | S | 15.00 | 6,000 | 90,000 | 200,819 | 206.8 K to 200.8 K (-2.90 %) |
| Feb 13 2014 | ECYT | ENDOCYTE INC | Low Philip S | Chief Science Offic ... | Option Exercise | M | 1.91 | 1,000 | 1,910 | 544 | |
| Feb 13 2014 | ECYT | ENDOCYTE INC | Low Philip S | Chief Science Offic ... | Buy | M | 1.91 | 1,000 | 1,910 | 206,819 | 205.8 K to 206.8 K (+0.49 %) |
| Feb 10 2014 | ECYT | ENDOCYTE INC | Taylor Beth | Corporate Controlle ... | Option Exercise | A | 11.11 | 10,850 | 120,544 | 10,850 | |
| Feb 10 2014 | ECYT | ENDOCYTE INC | Taylor Beth | Corporate Controlle ... | Grant | A | 0.00 | 5,425 | 0 | 7,147 | 1.7 K to 7.1 K (+315.04 %) |
| Feb 10 2014 | ECYT | ENDOCYTE INC | Sherman Michael A. | Chief Financial Off ... | Option Exercise | A | 11.11 | 45,000 | 499,950 | 45,000 | |
| Feb 10 2014 | ECYT | ENDOCYTE INC | Sherman Michael A. | Chief Financial Off ... | Grant | A | 0.00 | 7,500 | 0 | 80,798 | 73.3 K to 80.8 K (+10.23 %) |
| Feb 10 2014 | ECYT | ENDOCYTE INC | Nguyen Binh | VP of Medical Affai ... | Option Exercise | A | 11.11 | 45,000 | 499,950 | 45,000 | |
| Feb 10 2014 | ECYT | ENDOCYTE INC | Nguyen Binh | VP of Medical Affai ... | Grant | A | 0.00 | 7,500 | 0 | 10,200 | 2.7 K to 10.2 K (+277.78 %) |
| Feb 10 2014 | ECYT | ENDOCYTE INC | Brinkley Michael A. | VP OF QUALITY | Option Exercise | A | 11.11 | 37,500 | 416,625 | 37,500 | |
| Feb 10 2014 | ECYT | ENDOCYTE INC | Brinkley Michael A. | VP OF QUALITY | Grant | A | 0.00 | 6,250 | 0 | 6,250 | 0 to 6.3 K |
| Feb 10 2014 | ECYT | ENDOCYTE INC | Ellis P Ron | President and CEO | Option Exercise | A | 11.11 | 135,000 | 1,499,850 | 135,000 | |
| Feb 10 2014 | ECYT | ENDOCYTE INC | Ellis P Ron | President and CEO | Grant | A | 0.00 | 22,500 | 0 | 51,654 | 29.2 K to 51.7 K (+77.18 %) |
| Feb 10 2014 | ECYT | ENDOCYTE INC | Leamon Christopher P | Vice President of R ... | Option Exercise | A | 11.11 | 45,000 | 499,950 | 45,000 | |
| Feb 10 2014 | ECYT | ENDOCYTE INC | Leamon Christopher P | Vice President of R ... | Grant | A | 0.00 | 7,500 | 0 | 17,573 | 10.1 K to 17.6 K (+74.46 %) |
| Feb 10 2014 | ECYT | ENDOCYTE INC | Harper Scot | VP of CLINICAL OPER ... | Option Exercise | A | 11.11 | 45,000 | 499,950 | 45,000 | |
| Feb 10 2014 | ECYT | ENDOCYTE INC | Harper Scot | VP of CLINICAL OPER ... | Grant | A | 0.00 | 7,500 | 0 | 7,500 | 0 to 7.5 K |
| Feb 10 2014 | ECYT | ENDOCYTE INC | Lovejoy Chandra D | VP of Regulatory Af ... | Option Exercise | A | 11.11 | 37,500 | 416,625 | 37,500 | |
| Feb 10 2014 | ECYT | ENDOCYTE INC | Lovejoy Chandra D | VP of Regulatory Af ... | Grant | A | 0.00 | 6,250 | 0 | 6,250 | 0 to 6.3 K |
| Feb 10 2014 | ECYT | ENDOCYTE INC | Low Philip S | Chief Science Offic ... | Option Exercise | A | 11.11 | 45,000 | 499,950 | 45,000 | |
| Feb 10 2014 | ECYT | ENDOCYTE INC | Low Philip S | Chief Science Offic ... | Grant | A | 0.00 | 7,500 | 0 | 205,819 | 198.3 K to 205.8 K (+3.78 %) |
| Feb 10 2014 | ECYT | ENDOCYTE INC | Meek David D. | Chief Commercial Of ... | Option Exercise | A | 11.11 | 45,000 | 499,950 | 45,000 | |
| Feb 10 2014 | ECYT | ENDOCYTE INC | Meek David D. | Chief Commercial Of ... | Grant | A | 0.00 | 7,500 | 0 | 7,500 | 0 to 7.5 K |
| Feb 10 2014 | ECYT | ENDOCYTE INC | Ritter Allen R | VP of Manufacturing ... | Option Exercise | A | 11.11 | 30,000 | 333,300 | 30,000 | |
| Feb 10 2014 | ECYT | ENDOCYTE INC | Ritter Allen R | VP of Manufacturing ... | Grant | A | 0.00 | 5,000 | 0 | 20,722 | 15.7 K to 20.7 K (+31.80 %) |